Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer

Vakaramoko Diaby, Georges Adunlin, Simon B. Zeichner, Kiran Avancha, Gilberto Lopes, Stefan Gluck, Alberto J. Montero

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences